Powered by

Aristea Therapeutics Announces Formation of Scientific Advisory Board

Sep 12, 2019 - PR Newswire

PR Newswire

 Aristea Therapeutics (Aristea), a clinical-stage drug development company developing novel therapies to treat serious inflammatory diseases, today announced the formation of its Scientific Advisory Board (SAB), which is comprised of industry experts in inflammatory and dermatological disease drug development.  The SAB will work closely with Aristea's leadership to advance its lead therapeutic, RIST4721, for patients with palmoplantar pustulosis (PPP), a rare, chronic inflamm...